Pilot study tracks melatonin in pregnancy for future disease markers
NCT ID NCT03014245
First seen May 09, 2026 · Last updated May 09, 2026
Summary
This study looked at how melatonin, a hormone known for sleep and as an antioxidant, changes in the blood during each trimester of pregnancy. Researchers measured melatonin and its main breakdown product in 60 women to see if levels relate to pregnancy complications like high blood pressure. The goal was to gather information for larger studies on using melatonin as a biomarker or treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY TRANSIENT HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aberdeen Maternity Hospital (NHS Grampian)
Aberdeen, Aberdeenshire, AB25 2ZB, United Kingdom
Conditions
Explore the condition pages connected to this study.